Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 2.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 1.65 | 1.8 |
NAV | ₹107.44 | ₹137.74 |
Fund Started | 22 Aug 2005 | 30 Aug 2005 |
Fund Size | ₹23488.97 Cr | ₹8230.34 Cr |
Exit Load | Exit load of 0.10% if redeemed within 30 days. | Exit load of 1%, if redeemed within 90 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 28.76% | 37.23% |
3 Year | 11.73% | 13.80% |
5 Year | 16.19% | 17.61% |
1 Year
3 Year
5 Year
Equity | 97.52% | 96.42% |
Cash | 2.48% | 3.58% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 5.51% |
Kotak Mahindra Bank Ltd. | 5.28% |
Reliance Industries Ltd. | 4.91% |
ICICI Bank Ltd. | 3.37% |
Infosys Ltd. | 2.97% |
Mahindra & Mahindra Ltd. | 2.86% |
Larsen & Toubro Ltd. | 2.85% |
Bharti Airtel Ltd. | 2.73% |
Cognizant Technology Solutions Corp. | 2.48% |
Nuvoco Vistas Corporation Ltd. | 1.95% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 8.76% |
ICICI Bank Ltd. | 7.91% |
Infosys Ltd. | 7.01% |
Bharti Airtel Ltd. | 5.36% |
Reliance Industries Ltd. | 4.99% |
Larsen & Toubro Ltd. | 4.95% |
NTPC Ltd. | 4.63% |
Axis Bank Ltd. | 3.74% |
Sun Pharmaceutical Industries Ltd. | 3.45% |
Mahindra & Mahindra Ltd. | 3.28% |
Name | Rama Iyer Srinivasan | Dhaval Joshi |
Start Date | 08 Sep 2020 | 21 Nov 2022 |
Name
Start Date
Description | The scheme would invest in equities and equity related instruments of companies spanning the entire market capitalization spectrum. The fund will invest 50-90 per cent in large-cap stocks, 10-40 per cent in mid-cap stocks and upto 10 per cent in small-cap stocks. | The Scheme seeks to achieve long term capital appreciation by investing in upto 30 companies with long term sustainable competitive advantage and growth potential |
Launch Date | 22 Aug 2005 | 30 Aug 2005 |
Description
Launch Date